Category: TVAM

Results of Study Published: Treating Autonomic Dysfunction in MS Patients

June 11, 2020 at 8:15 pm , by Synergy Health

Michael Arata, MD of Synergy Health Concepts and Zohara Sternberg, PhD published the results of a new study on Transvascular Autonomic Modulation (TVAM) in the June 2014 edition of the Journal of Endovascular Therapy. TVAM is an innovative treatment that may provide relief for MS patients suffering from symptoms of

New TVAM Study Published in Acta Phlebologica

No comments

May 29, 2020 at 2:52 pm , by Synergy Health

Michael Arata MD of Synergy Health Concepts published the results of a new study into the safety and effectiveness of the TVAM procedure in patients with autonomic dysfunction. The study was published in the April 2014 edition of Acta Phlebologica: A Journal on Phlebology. Transvascular autonomic modulation (TVAM) is a

A New Approach to Treating MS Patients

No comments

May 28, 2020 at 9:08 am , by Michael Arata MD

As MS patients are all too well aware, multiple sclerosis can cause a wide range of symptoms, from weakness and numbness to visual changes. But most MS patients don’t realize that they are very likely to have another condition known as autonomic dysfunction, or dysautonomia, and that it is dysautonomia

New Study Finds Relationship Between Fibromylagia and Autonomic Dysfunction; Suggests New Treatment Options

No comments

April 18, 2020 at 8:33 pm , by Michael Arata MD

A recent study published in the Journal of Clinical Rheumatology explores the connection between fibromyalgia and sympathetic nervous system dysfunction. This meta-study found that 65% of case-control studies found in the PubMed and EMBASE databases described “sympathetic nervous system predominance” as the “common clustering underlying pathogenesis”1, meaning that the onset

Treating Fibromyalgia Patients in a Whole New Way

Comments are closed

February 18, 2020 at 12:05 pm , by Michael Arata MD

Fibromyalgia is a difficult syndrome to diagnose and to treat. Worse yet for fibro patients, a large portion of the medical community still does not recognize fibromyalgia as a real or serious condition. What treatments do exist are inconsistent in their effectiveness and largely treat very specific symptoms like pain

Dr. Arata Discusses TVAM treatment for Patients with Lyme Disease on Lyme Light Radio

No comments

January 14, 2020 at 10:18 am , by Synergy Health

On Jan 8, 2020, Katina Makris of Lyme Light Radio (Transformation Talk Radio) interviewed Dr. Arata about a new treatment for patients with Lyme disease. The procedure, TVAM (transvascular autonomic modulation) is an endovascular procedure with a therapeutic goal of restoring balance to the body by improving autonomic function.

Dr. Arata Interviewed on New Treatment for Patients with Fibromyalgia

No comments

January 10, 2020 at 2:36 pm , by Synergy Health

Early in December of 2013, Amy Mullholand “The Fibro Frog” interviewed Dr. Arata about a new treatment for Fibromylagia patients called TVAM (transvascular autonomic modulation). In the interview Dr. Arata explains the connection between small fiber neuropathy (inflammation of the autonomic nerve fibers) and fibromyalgia, and how TVAM is able

Studies Investigate Relationship Between New Treatment and Reduction in Dysautonomia Symptoms in MS Patients

No comments

December 15, 2020 at 11:23 pm , by Synergy Health

Synergy Health has published a new study, the first in a series, investigating the relationship between treatment for CCSVI (and its successor treatment, TVAM therapy) and the improvement of the symptoms of dysautonomia among M.S. Patients and other groups suffering from autonomic dysfunction. Read our latest study here: http://phl.sagepub.com/content/early/2020/11/18 While

A Promising New Treatment for Dysautonomia Patients

No comments

August 12, 2020 at 6:18 am , by Michael Arata MD

Most patients diagnosed with isolated or “pure” dysautonomia – autonomic dysfunction with no underlying neurological condition – generally first seek medical treatment for cardiovascular issues, such as POTS (where the heart rate fluctuates based on body position) or syncope (the tendency to pass out frequently). As a result, dysautonomia is

The Current Status of CCSVI Treatment

No comments

July 21, 2020 at 12:57 pm , by Michael Arata MD

Since the condition known as chronic cerebrospinal venous insufficiency (CCSVI) was first described by Dr. Paolo Zamboni in 2008, the relationship between this condition and MS has been investigated and rigorously debated. Yet while Zamboni’s original study saw an over 90% correlation between MS and CCSVI, later studies have cast